Novavax to Participate in BofA Securities 2025 Health Care Conference

About this update from Novavax, Inc.

[{"type":"text","content":"GAITHERSBURG, Md., May 7, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the BofA Securities 2025 Health Care Conference.\nConference Details:\nFireside Chat\nDate:\nWednesday, May 14, 2025\nTime:\n3:00 – 3:30 p.m. Pacific Time (PT)\nLocation:\nLas Vegas, NV\nConference\nEvent:\nInvestor Meetings\nDate:\nWednesday, May 14, 2025\nA webcast of the fireside chat will be available on the Events & Presentations page of the Company's website at ir.novavax.com. A replay of the webcast will be available for 30 days.\nAbout NovavaxNovavax, Inc. (Nasdaq: NVAX) tackles some of the world's most significant health challenges by leveraging its scientific expertise in vaccines and its cutting-edge technology platform, which includes protein-based nanoparticles and its Matrix-M® adjuvant. The Company's growth strategy is focused on building new and diversified partnerships via the out-licensing of its technology platform and vaccine assets earlier in the development process. These strategic collaborations are fueled by smart investments in a growing early-stage pipeline starting with the Company's core expertise in infectious disease and potentially expanding into other disease areas. Please visit novavax.com and LinkedIn for more information. \nContacts: \nInvestors Luis Sanay, CFA [email protected]\nMediaGiovanna [email protected]\n\n\n\n\n\n View original content to download multimedia:https://www.prnewswire.com/news-releases/novavax-to-participate-in-bofa-securities-2025-health-care-conference-302447909.html\nSOURCE Novavax, Inc.","length":11093,"tagName":"div"}]

More updates from Novavax, Inc.